Abstract
In the issue entitled "Role of Medical Imaging in Cancers", 33 papers have been collected (23 original articles, 8 reviews, 1 brief report and 1 perspective) [...].
Highlights
In the issue entitled “Role of Medical Imaging in Cancers”, 33 papers have been collected (23 original articles, 8 reviews, 1 brief report and 1 perspective)
The first topic has continuously gained interest in last years, in particular after the introduction of prostate specific membrane antigen (PSMA)-based radiopharmaceuticals, as extensively reported by Hoffmann et al [18] in a cohort of more than 580 patients with recurrent prostate cancer (PCa), showing that, after radical prostatectomy, PSMA positron emission tomography (PET)/computed tomography (CT) was able to detect the presence of recurrent disease in more than 50% of patients with a PSA level < 1.24 ng/mL
Fanti et al [20] underlined that, there is a large amount of data on PSMA PET in PCa, the diagnostic procedures are still underutilized in clinical practice
Summary
In the issue entitled “Role of Medical Imaging in Cancers”, 33 papers have been collected (23 original articles, 8 reviews, 1 brief report and 1 perspective). All the papers focus on different topics, mainly on the role of positron emission tomography (PET) imaging in the management of oncological patients. The majority of papers are focused on prostate cancer (PCa) and radiomics.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
